Chad Mire, PhD

  • 1480 Citations
  • 24 h-Index
20042020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2004 2019

2019

Antibody therapy for Lassa fever

Cross, R., Hastie, K. M., Mire, C., Robinson, J. E., Geisbert, T., Branco, L. M., Ollmann Saphire, E. & Garry, R. F., Aug 1 2019, In : Current Opinion in Virology. 37, p. 97-104 8 p.

Research output: Contribution to journalReview article

Lassa Fever
Lassa virus
Monoclonal Antibodies
Antibodies
Epitopes
8 Citations (Scopus)

A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates

Bornholdt, Z. A., Herbert, A. S., Mire, C., He, S., Cross, R., Wec, A. Z., Abelson, D. M., Geisbert, J. B., James, R. M., Rahim, M. N., Zhu, W., Borisevich, V., Banadyga, L., Gunn, B. M., Agans, K. N., Wirchnianski, A. S., Goodwin, E., Tierney, K., Shestowsky, W. S., Bohorov, O. & 13 others, Bohorova, N., Velasco, J., Ailor, E., Kim, D., Pauly, M. H., Whaley, K. J., Alter, G., Walker, L. M., Chandran, K., Zeitlin, L., Qiu, X., Geisbert, T. & Dye, J. M., Jan 9 2019, In : Cell Host and Microbe. 25, 1, p. 49-58.e5

Research output: Contribution to journalArticle

Ebolavirus
Ferrets
Primates
Antibodies
Ebola Hemorrhagic Fever

Author Correction: Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants (Scientific Reports, (2017), 7, 1, (9730), 10.1038/s41598-017-09963-y)

Versteeg, K., Menicucci, A. R., Woolsey, C., Mire, C., Geisbert, J. B., Cross, R., Agans, K. N., Jeske, D., Messaoudi, I. & Geisbert, T., Dec 1 2019, In : Scientific reports. 9, 1, 7329.

Research output: Contribution to journalComment/debate

Open Access
Ebolavirus
Overlapping Genes
Gene Expression
Infection

A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge

Woolsey, C., Menicucci, A. R., Cross, R., Luthra, P., Agans, K. N., Borisevich, V., Geisbert, J. B., Mire, C., Fenton, K. A., Jankeel, A., Anand, S., Ebihara, H., Geisbert, T., Messaoudi, I. & Basler, C. F., Sep 17 2019, In : Cell Reports. 28, 12, p. 3032-3046.e6

Research output: Contribution to journalArticle

Open Access
Ebolavirus
Viruses
Virulence
Immunity
Interferon Type I
4 Citations (Scopus)

Current Ebola Virus Vaccine Progress

Marzi, A. & Mire, C., Jan 1 2019, (Accepted/In press) In : BioDrugs.

Research output: Contribution to journalArticle

Ebola Vaccines
Vaccines
Immunity
Ebola Hemorrhagic Fever
Ebolavirus

The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus

Jasenosky, L. D., Cadena, C., Mire, C. E., Borisevich, V., Haridas, V., Ranjbar, S., Nambu, A., Bavari, S., Soloveva, V., Sadukhan, S., Cassell, G. H., Geisbert, T. W., Hur, S. & Goldfeld, A. E., Sep 27 2019, In : iScience. 19, p. 1279-1290 12 p.

Research output: Contribution to journalArticle

Open Access
nitazoxanide
Ebolavirus
Antiviral Agents
Protein Kinases
Immune Evasion

Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease

Mire, C., Geisbert, J. B., Agans, K. N., Versteeg, K. M., Deer, D. J., Satterfield, B. A., Fenton, K. A. & Geisbert, T., Jun 1 2019, In : Emerging infectious diseases. 25, 6, p. 1144-1152 9 p.

Research output: Contribution to journalArticle

Open Access
Nipah Virus
Vesicular Stomatitis
Virus Diseases
Primates
Vaccines
3 Citations (Scopus)

Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever

Rodriguez, S., Cross, R., Fenton, K. A., Bente, D., Mire, C. & Geisbert, T., Dec 1 2019, In : Scientific reports. 9, 1, 7755.

Research output: Contribution to journalArticle

Open Access
Crimean-Congo hemorrhagic fever virus
Crimean Hemorrhagic Fever
Congo
Vesicular Stomatitis
Vaccines
2018
8 Citations (Scopus)

A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates

Callendret, B., Vellinga, J., Wunderlich, K., Rodriguez, A., Steigerwald, R., Dirmeier, U., Cheminay, C., Volkmann, A., Brasel, T., Carrion, R., Giavedoni, L. D., Patterson, J. L., Mire, C., Geisbert, T., Hooper, J. W., Weijtens, M., Hartkoorn-Pasma, J., Custers, J., Pau, M. G., Schuitemaker, H. & 1 others, Zahn, R., Feb 1 2018, In : PLoS One. 13, 2, e0192312.

Research output: Contribution to journalArticle

Marburgvirus
Filoviridae
Ebolavirus
Viruses
Primates
1 Citation (Scopus)

Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates

Gilchuk, P., Mire, C., Geisbert, J. B., Agans, K. N., Deer, D. J., Cross, R., Slaughter, J. C., Flyak, A. I., Mani, J., Pauly, M. H., Velasco, J., Whaley, K. J., Zeitlin, L., Geisbert, T. & Crowe, J. E., Nov 22 2018, In : The Journal of infectious diseases. 218, 5, p. S565-S573

Research output: Contribution to journalArticle

Virus Diseases
Primates
Monoclonal Antibodies
Viruses
Macaca mulatta
5 Citations (Scopus)

Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo)

Cross, R., Mire, C., Agans, K. N., Borisevich, V., Fenton, K. A. & Geisbert, T., Nov 22 2018, In : The Journal of infectious diseases. 218, 5, p. S448-S452

Research output: Contribution to journalArticle

Marburgvirus
Ferrets
Ebolavirus
Viremia
Immunity
2 Citations (Scopus)

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates

Woolsey, C., Geisbert, J. B., Matassov, D., Agans, K. N., Borisevich, V., Cross, R., Deer, D. J., Fenton, K. A., Eldridge, J. H., Mire, C. & Geisbert, T., Nov 22 2018, In : The Journal of infectious diseases. 218, 5, p. S582-S587

Research output: Contribution to journalArticle

Marburgvirus
Angola
Vesicular Stomatitis
Primates
Macaca
28 Citations (Scopus)

Post-exposure treatments for Ebola and Marburg virus infections

Cross, R., Mire, C., Feldmann, H. & Geisbert, T., Jun 1 2018, In : Nature Reviews Drug Discovery. 17, 6, p. 413-434 22 p.

Research output: Contribution to journalReview article

Ebola Hemorrhagic Fever
Marburgvirus
Ebolavirus
Primates
Biological Warfare Agents
8 Citations (Scopus)

Single-dose trivalent VesiculoVax vaccine protects macaques from lethal Ebolavirus and Marburgvirus challenge

Matassov, D., Mire, C., Latham, T., Geisbert, J. B., Xu, R., Ota-Setlik, A., Agans, K. N., Kobs, D. J., Wendling, M. Q. S., Burnaugh, A., Rudge, T. L., Sabourin, C. L., Egan, M. A., Clarke, D. K., Geisbert, T. & Eldridge, J. H., Feb 1 2018, In : Journal of Virology. 92, 3, e01190-17.

Research output: Contribution to journalArticle

Marburgvirus
Ebolavirus
Filoviridae
Vesiculovirus
Vesicular Stomatitis
2017
7 Citations (Scopus)

Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo

Warfield, K. L., Warren, T. K., Qiu, X., Wells, J., Mire, C., Geisbert, J. B., Stuthman, K. S., Garza, N. L., Van Tongeren, S. A., Shurtleff, A. C., Agans, K. N., Wong, G., Callahan, M. V., Geisbert, T., Klose, B., Ramstedt, U. & Treston, A. M., Feb 1 2017, In : Antiviral Research. 138, p. 22-31 10 p.

Research output: Contribution to journalArticle

Marburgvirus
Antiviral Agents
Infection
Primates
Human Influenza
8 Citations (Scopus)

Disposable cartridge platform for rapid detection of viral hemorrhagic fever viruses

Scherr, S. M., Freedman, D. S., Agans, K. N., Rosca, A., Carter, E., Kuroda, M., Fawcett, H. E., Mire, C., Geisbert, T., Ünlü, M. S. & Connor, J. H., 2017, In : Lab on a Chip - Miniaturisation for Chemistry and Biology. 17, 5, p. 917-925 9 p.

Research output: Contribution to journalArticle

Viral Hemorrhagic Fevers
Viruses
Virion
Virus Attachment
Imaging techniques
5 Citations (Scopus)

Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses

Daaboul, G. G., Freedman, D. S., Scherr, S. M., Carter, E., Rosca, A., Bernstein, D., Mire, C., Agans, K. N., Hoenen, T., Geisbert, T., Selim Ünlü, M. & Connor, J. H., Jun 1 2017, In : PLoS One. 12, 6, e0179728.

Research output: Contribution to journalArticle

Zika virus
Ebolavirus
Viruses
virion
Virion

Evaluation of medical countermeasures against ebolaviruses in nonhuman primate models

Mire, C. & Geisbert, T., 2017, Methods in Molecular Biology. Humana Press Inc., Vol. 1628. p. 293-307 15 p. (Methods in Molecular Biology; vol. 1628).

Research output: Chapter in Book/Report/Conference proceedingChapter

Ebolavirus
Primates
Vaccines
Licensure
Primate Diseases
25 Citations (Scopus)

Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

Mire, C., Cross, R., Geisbert, J. B., Borisevich, V., Agans, K. N., Deer, D. J., Heinrich, M. L., Rowland, M. M., Goba, A., Momoh, M., Boisen, M. L., Grant, D. S., Fullah, M., Khan, S. H., Fenton, K. A., Robinson, J. E., Branco, L. M., Garry, R. F. & Geisbert, T., Oct 1 2017, In : Nature Medicine. 23, 10, p. 1146-1149 4 p.

Research output: Contribution to journalArticle

Lassa Fever
Lassa virus
Western Africa
Macaca
Viruses
10 Citations (Scopus)

Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants

Versteeg, K., Menicucci, A. R., Woolsey, C., Mire, C., Geisbert, J. B., Cross, R., Agans, K. N., Jeske, D., Messaoudi, I. & Geisbert, T., Dec 1 2017, In : Scientific Reports. 7, 1, 9730.

Research output: Contribution to journalArticle

Ebolavirus
Democratic Republic of the Congo
Infection
Disease Progression
Genes
6 Citations (Scopus)

Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop

Mire, C. & Geisbert, T., Aug 1 2017, In : Trends in Molecular Medicine. 23, 8, p. 669-671 3 p.

Research output: Contribution to journalShort survey

Ebolavirus
Antiviral Agents
Glycoproteins
Vaccines
Membrane Fusion
4 Citations (Scopus)

siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease

Thi, E. P., Mire, C., Lee, A. C. H., Geisbert, J. B., Ursic-Bedoya, R., Agans, K. N., Robbins, M., Deer, D. J., Cross, R., Kondratowicz, A. S., Fenton, K. A., MacLachlan, I. & Geisbert, T., Dec 1 2017, In : Journal of Clinical Investigation. 127, 12, p. 4437-4448 12 p.

Research output: Contribution to journalArticle

Marburg Virus Disease
Marburgvirus
Primates
Small Interfering RNA
Viruses
23 Citations (Scopus)

Therapeutic treatment of marburg and ravn virus infection in nonhuman primates with a human monoclonal antibody

Mire, C., Geisbert, J. B., Borisevich, V., Fenton, K. A., Agans, K. N., Flyak, A. I., Deer, D. J., Steinkellner, H., Bohorov, O., Bohorova, N., Goodman, C., Hiatt, A., Kim, D. H., Pauly, M. H., Velasco, J., Whaley, K. J., Crowe, J. E., Zeitlin, L. & Geisbert, T., Apr 5 2017, In : Science Translational Medicine. 9, 384, eaai8711.

Research output: Contribution to journalArticle

Marburgvirus
Virus Diseases
Primates
Monoclonal Antibodies
Ebola Hemorrhagic Fever
12 Citations (Scopus)

Transcriptome analysis of circulating immune cell subsets highlight the role of monocytes in Zaire Ebola Virus Makona pathogenesis

Menicucci, A. R., Versteeg, K., Woolsey, C., Mire, C., Geisbert, J. B., Cross, R., Agans, K. N., Jankeel, A., Geisbert, T. & Messaoudi, I., Oct 4 2017, In : Frontiers in Immunology. 8, OCT, 1372.

Research output: Contribution to journalArticle

Ebolavirus
Democratic Republic of the Congo
Gene Expression Profiling
Monocytes
Ebola Hemorrhagic Fever
2016
32 Citations (Scopus)

Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins

Edwards, M. R., Liu, G., Mire, C., Sureshchandra, S., Luthra, P., Yen, B., Shabman, R. S., Leung, D. W., Messaoudi, I., Geisbert, T., Amarasinghe, G. K. & Basler, C. F., Feb 23 2016, In : Cell Reports. 14, 7, p. 1632-1640 9 p.

Research output: Contribution to journalArticle

Marburgvirus
Viruses
Interferons
Ebolavirus
RNA
19 Citations (Scopus)

Ebola virus vaccines – reality or fiction?

Mire, C., Geisbert, T., Feldmann, H. & Marzi, A., Nov 1 2016, In : Expert Review of Vaccines. 15, 11, p. 1421-1430 10 p.

Research output: Contribution to journalReview article

Ebola Vaccines
Ebolavirus
Vaccines
Western Africa
Primates
1 Citation (Scopus)

Inhibition of the host antiviral response by Nipah virus: Current understanding and future perspectives

Satterfield, B. A., Geisbert, T. & Mire, C., May 1 2016, In : Future Virology. 11, 5, p. 331-344 14 p.

Research output: Contribution to journalArticle

Nipah Virus
Antiviral Agents
Viral Proteins
Acute Disease
Encephalitis
8 Citations (Scopus)

Isolation and characterization of a novel gammaherpesvirus from a microbat cell line

Shabman, R. S., Shrivastava, S., Tsibane, T., Attie, O., Jayaprakash, A., Mire, C., Dilley, K. E., Puri, V., Stockwell, T. B., Geisbert, T., Sachidanandam, R. & Basler, C. F., Jan 1 2016, In : mSphere. 1, 1, e00070-15.

Research output: Contribution to journalArticle

Rhadinovirus
Open Reading Frames
High-Throughput Nucleotide Sequencing
Cell Line
Vero Cells
12 Citations (Scopus)

Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly from Blood

Benzine, J. W., Brown, K. M., Agans, K. N., Godiska, R., Mire, C., Gowda, K., Converse, B., Geisbert, T., Mead, D. A. & Chander, Y., Oct 15 2016, In : Journal of Infectious Diseases. 214, p. S234-S242

Research output: Contribution to journalArticle

Point-of-Care Systems
Ebolavirus
Molecular Pathology
Routine Diagnostic Tests
RNA-Directed DNA Polymerase
10 Citations (Scopus)

Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus

Mire, C., Geisbert, J. B., Agans, K. N., Deer, D. J., Fenton, K. A. & Geisbert, T., Oct 15 2016, In : Journal of Infectious Diseases. 214, p. S263-S267

Research output: Contribution to journalArticle

Ebolavirus
Primates
Ebola Hemorrhagic Fever
Aerosols
Infection
17 Citations (Scopus)

Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates

Mire, C., Geisbert, J. B., Agans, K. N., Thi, E. P., Lee, A. C. H., Fenton, K. A. & Geisbert, T., Oct 15 2016, In : Journal of Infectious Diseases. 214, p. S367-S374

Research output: Contribution to journalArticle

Ebola Hemorrhagic Fever
Ebolavirus
Passive Immunization
Primates
Democratic Republic of the Congo
22 Citations (Scopus)

Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy

Mire, C., Satterfield, B. A., Geisbert, J. B., Agans, K. N., Borisevich, V., Yan, L., Chan, Y. P., Cross, R., Fenton, K. A., Broder, C. C. & Geisbert, T., Aug 3 2016, In : Scientific Reports. 6, 30916.

Research output: Contribution to journalArticle

Nipah Virus
Bangladesh
Malaysia
Primates
Antibodies
18 Citations (Scopus)

Polyamines and hypusination are required for ebolavirus gene expression and replication

Olsen, M. E., Filone, C. M., Rozelle, D., Mire, C., Agans, K. N., Hensley, L. & Connor, J. H., Jul 1 2016, In : mBio. 7, 4, e00882-16.

Research output: Contribution to journalArticle

Ebolavirus
Polyamines
Eukaryotic Initiation Factors
Gene Expression
Viral Structures
12 Citations (Scopus)

Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA

Thi, E. P., Lee, A. C. H., Geisbert, J. B., Ursic-Bedoya, R., Agans, K. N., Robbins, M., Deer, D. J., Fenton, K. A., Kondratowicz, A. S., MacLachlan, I., Geisbert, T. & Mire, C., Aug 22 2016, In : Nature Microbiology. 1, 16142.

Research output: Contribution to journalArticle

Ebolavirus
Sudan
Primates
Small Interfering RNA
Nanoparticles
10 Citations (Scopus)

Single-vector, single-injection recombinant vesicular stomatitis virus vaccines against high-containment viruses

Whitt, M. A., Geisbert, T. & Mire, C., Apr 1 2016, Methods in Molecular Biology. Humana Press Inc., Vol. 1403. p. 295-311 17 p. (Methods in Molecular Biology; vol. 1403).

Research output: Chapter in Book/Report/Conference proceedingChapter

Vesicular Stomatitis
Vaccines
Viruses
Injections
Reverse Genetics
20 Citations (Scopus)

Targeting innate immunity for antiviral therapy through small molecule agonists of the RLR pathway

Pattabhi, S., Wilkins, C. R., Dong, R., Knoll, M. L., Posakony, J., Kaiser, S., Mire, C., Wang, M. L., Ireton, R. C., Geisbert, T., Bedard, K. M., Iadonato, S. P., Loo, Y. M. & Gale, M., 2016, In : Journal of Virology. 90, 5, p. 2372-2387 16 p.

Research output: Contribution to journalArticle

Interferon Regulatory Factor-3
Innate Immunity
agonists
Antiviral Agents
viruses
37 Citations (Scopus)

The domestic ferret (mustela putorius furo) as a lethal infection model for 3 species of ebolavirus

Cross, R., Mire, C., Borisevich, V., Geisbert, J. B., Fenton, K. A. & Geisbert, T., Aug 15 2016, In : Journal of Infectious Diseases. 214, 4, p. 565-569 5 p.

Research output: Contribution to journalArticle

Ebolavirus
Ferrets
Animal Models
Primate Diseases
Filoviridae
24 Citations (Scopus)

The synthetic antiviral drug arbidol inhibits globally prevalent pathogenic viruses

Pécheur, E. I., Borisevich, V., Halfmann, P., Morrey, J. D., Smee, D. F., Prichard, M., Mire, C., Kawaoka, Y., Geisbert, T. & Polyak, S. J., 2016, In : Journal of Virology. 90, 6, p. 3086-3092 7 p.

Research output: Contribution to journalArticle

antiviral agents
Antiviral Agents
Zaire Ebola virus
Viruses
viruses
19 Citations (Scopus)

Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies

Cross, R., Mire, C., Branco, L. M., Geisbert, J. B., Rowland, M. M., Heinrich, M. L., Goba, A., Momoh, M., Grant, D. S., Fullah, M., Khan, S. H., Robinson, J. E., Geisbert, T. & Garry, R. F., Sep 1 2016, In : Antiviral Research. 133, p. 218-222 5 p.

Research output: Contribution to journalArticle

Lassa virus
Virus Diseases
Guinea Pigs
Monoclonal Antibodies
Lassa Fever
2015
39 Citations (Scopus)

Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses

Meyer, M., Garron, T., Lubaki, N. M., Mire, C., Fenton, K. A., Klages, C., Olinger, G. G., Geisbert, T., Collins, P. L. & Bukreyev, A., Aug 3 2015, In : Journal of Clinical Investigation. 125, 8, p. 3241-3255 15 p.

Research output: Contribution to journalArticle

Ebola Vaccines
Ebolavirus
Primates
Vaccines
T-Lymphocytes
26 Citations (Scopus)

Analytical performance characteristics of the cepheid GeneXpert Ebola Assay for the detection of Ebola virus

Pinsky, B. A., Sahoo, M. K., Sandlund, J., Kleman, M., Kulkarni, M., Grufman, P., Nygren, M., Kwiatkowski, R., Baron, E. J., Tenover, F., Denison, B., Higuchi, R., Van Atta, R., Beer, N. R., Carrillo, A. C., Naraghi-Arani, P., Mire, C., Ranadheera, C., Grolla, A., Lagerqvist, N. & 1 others, Persing, D. H., Nov 1 2015, In : PLoS One. 10, 11, e0142216.

Research output: Contribution to journalArticle

Ebolavirus
Viruses
Assays
assays
Virus Inactivation
38 Citations (Scopus)

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses

Safronetz, D., Mire, C., Rosenke, K., Feldmann, F., Haddock, E., Geisbert, T. & Feldmann, H., Apr 17 2015, In : PLoS Neglected Tropical Diseases. 9, 4, e0003736.

Research output: Contribution to journalArticle

Lassa Fever
Lassa virus
Vesicular Stomatitis
Macaca
Guinea Pigs
20 Citations (Scopus)

A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs

Mire, C., Geisbert, J. B., Versteeg, K. M., Mamaeva, N., Agans, K. N., Geisbert, T. & Connor, J. H., Oct 1 2015, In : Journal of Infectious Diseases. 212, p. S384-S388

Research output: Contribution to journalArticle

Ebolavirus
Guinea Pigs
Marburgvirus
Vaccines
Democratic Republic of the Congo
23 Citations (Scopus)

Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model

Cross, R., Fenton, K. A., Geisbert, J. B., Ebihara, H., Mire, C. & Geisbert, T., Oct 1 2015, In : Journal of Infectious Diseases. 212, p. S258-S270

Research output: Contribution to journalArticle

Marburgvirus
Angola
Guinea Pigs
Virus Diseases
Viremia
9 Citations (Scopus)

Current and emerging strategies for the diagnosis, prevention and treatment of Lassa fever

Hartnett, J. N., Boisen, M. L., Oottamasathien, D., Jones, A. B., Millett, M. M., Nelson, D. S., Muncy, I. J., Goba, A., Momoh, M., Fullah, M., Mire, C., Geisbert, J. B., Geisbert, T., Holton, D. L., Rouelle, J. A., Kannadka, C. B., Reyna, A. A., Moses, L. M., Khan, S. H., Gevao, S. M. & 6 others, Grant, D. S., Robinson, J. E., Happi, C., Pitts, K. R., Garry, R. F. & Branco, L. M., May 1 2015, In : Future Virology. 10, 5, p. 559-584 26 p.

Research output: Contribution to journalArticle

Lassa Fever
Lassa virus
Western Africa
Bioterrorism
Virus Diseases
2 Citations (Scopus)

Erratum: Analytical performance characteristics of the cepheid genexpert ebola assay for the detection of ebola virus (PLoS One)

Pinsky, B. A., Sahoo, M. K., Sandlund, J., Kleman, M., Kulkarni, M., Grufman, P., Nygren, M., Kwiatkowski, R., Baron, E. J., Tenover, F., Denison, B., Higuchi, R., Van Atta, R., Beer, N. R., Carrillo, A. C., Naraghi-Arani, P., Mire, C., Ranadheera, C., Grolla, A., Lagerqvist, N. & 1 others, Persing, D. H., Dec 1 2015, In : PLoS One. 10, 12, 0145896.

Research output: Contribution to journalArticle

134 Citations (Scopus)

Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

Thi, E. P., Mire, C., Lee, A. C. H., Geisbert, J. B., Zhou, J. Z., Agans, K. N., Snead, N. M., Deer, D. J., Barnard, T. R., Fenton, K. A., Maclachlan, I. & Geisbert, T., May 21 2015, In : Nature. 521, 7552, p. 362-365 4 p.

Research output: Contribution to journalArticle

Ebolavirus
Nanoparticles
Primates
Small Interfering RNA
Disease Outbreaks
28 Citations (Scopus)

Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig

Cross, R., Fenton, K. A., Geisbert, J. B., Mire, C. & Geisbert, T., Oct 1 2015, In : Journal of Infectious Diseases. 212, p. S305-S315

Research output: Contribution to journalArticle

Ebolavirus
Democratic Republic of the Congo
Guinea Pigs
Primates
Ebola Hemorrhagic Fever
63 Citations (Scopus)

Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus

Mire, C., Matassov, D., Geisbert, J. B., Latham, T. E., Agans, K. N., Xu, R., Ota-Setlik, A., Egan, M. A., Fenton, K. A., Clarke, D. K., Eldridge, J. H. & Geisbert, T., Apr 30 2015, In : Nature. 520, 7549, p. 688-691 4 p.

Research output: Contribution to journalArticle

Ebolavirus
Attenuated Vaccines
Democratic Republic of the Congo
Primates
Vaccines
17 Citations (Scopus)

The immunomodulating v and W proteins of Nipah virus determine disease course

Satterfield, B. A., Cross, R., Fenton, K. A., Agans, K. N., Basler, C. F., Geisbert, T. & Mire, C., Jun 24 2015, In : Nature Communications. 6, 7483.

Research output: Contribution to journalArticle

viruses
Virus Diseases
Nipah Virus
Viruses
proteins